William E. Rote
Chief Research Officer · Travere Therapeutics, Inc.
- 2026
- Sep 18, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies William E. Rote files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Eric M. Dube - $41.35M in TVTX purchases and sales in the last 12 months
- Peter Heerma - $18.77M in TVTX purchases and sales in the last 12 months
- Elizabeth E. Reed - $7.02M in TVTX purchases and sales in the last 12 months
- Christopher R. Cline - $4.64M in TVTX purchases and sales in the last 12 months
- Jula Inrig - $4.53M in TVTX purchases and sales in the last 12 months
- Sandra Calvin - $3.90M in TVTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is William E. Rote?
William E. Rote is a corporate insider, tracked as Chief Research Officer of Travere Therapeutics, Inc. (TVTX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has William E. Rote submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has William E. Rote been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($14.02M) across all tracked filings.
